Pages
- cGMP iPSCs
- Manufacturing Science & Technology
- Quality & Regulatory Compliance
- Supply Chain & Logistics
- Process & Analytical Development
- Sustainability
- Clinical & Commercial Manufacturing
- Training Academy
- Why RoslinCT
- Privacy Policy
- About
- Contact
- Insights
- Home
- Services
- Facilities
- Careers
- Terms of Use
Posts by category
- Category: Blog
- Four Keys to Reducing Variability in the Cell Therapy Process
- The Build Versus Buy Decision
- Tackling the Cell Therapy Supply Chain
- RoslinCT Boston’s (former Lykan Bio) State-of-the-Art, Purpose-Built Cell Therapy Facility
- Insights about London Climate Action Week
- A Checklist for a Successful Cell Therapy Tech Transfer
- Category: News
- State-of-the-art manufacturing facility opens in Scottish capital
- RoslinCT announces the establishment of a Cell and Gene Training Academy
- RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board
- RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
- RoslinCT and Lykan Bioscience Announce the Addition of Six cGMP Suites to Meet Growing Demand
- RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
- RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings
- RoslinCT and Lykan Bioscience Announce the Establishment of a Scientific Advisory Board
- RoslinCT Boston (former Lykan Bioscience) Appoints Barbara Ressler, Ph.D. as Vice President, Manufacturing Process Sciences
- RoslinCT Appoints Alexandra Brownfield as Head of Business Development
- RoslinCT Appoints Lee Warren as Chief Financial Officer
- RoslinCT continues its growth plans by expanding its operations at Edinburgh Technopole
- Life Sciences in Scotland: How Edinburgh Technopole is Driving Innovation
- RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK
- RoslinCT Announces the Appointment of Peter Coleman as CEO
- GHO Capital invests in RoslinCT, a leading cell therapy CDMO
- RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board
- Category: Resources
Team
- Derek Hei, Ph.D.
- Michael Mendicino, Ph.D.
- Michael Kalos, Ph.D.
- Margit Jeschke, Ph.D.
- Michael Chambers
- Kenneth LeClair, Ph.D.
- Christopher (CJ) Burnes
- Peter Crowley
- Geoffrey Hamilton-Fairley
- Alan MacKay
- Andrea Ponti
- Ian McCubbin
- Barbara Ressler
- Jay Blackington
- Kathy Burri
- Matthew Treon
- Sheli Streck
- Patrick Lucy
- Adam Liddle
- Callum Watson
- Lynda Brown
- Alexandra Brownfield
- Kevin Bruce
- Jane Fraser
- Lee Warren, FCA
- Peter Coleman